Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KROOK JE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tefferi, A; Li, CY; Reeder, CB; Geyer, SM; Allmer, C; Levitt, R; Michalak, JC; Addo, F; Krook, JE; Witzig, TE; Schaefer, PL; Mailliard, JA
      A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

      LEUKEMIA
    2. Edmonson, JH; Suman, VJ; Dalton, RJ; Bro, WC; Gallenberg, MM; Long, HJ; Levitt, R; Hatfield, AK; Krook, JE; Mailliard, JA; Gerstner, JB
      Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study

      CANCER INVESTIGATION
    3. Stocchi, L; Nelson, H; Sargent, DJ; O'Connell, MJ; Tepper, JE; Krook, JE; Beart, R
      Impact of surgical and pathologic variables in rectal cancer: A United States Community and Cooperative Group Report

      JOURNAL OF CLINICAL ONCOLOGY
    4. Sloan, JA; Loprinzi, CL; Laurine, JA; Novotny, PJ; Vargas-Chanes, D; Krook, JE; O'Connell, MJ; Kugler, JW; Tirona, MT; Kardinal, CG; Wiesenfeld, M; Tschetter, LK; Hatfield, AK; Schaefer, PL
      A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index

      JOURNAL OF CLINICAL ONCOLOGY
    5. Pandya, KJ; Yeap, BY; Weiner, LM; Krook, JE; Erban, JK; Schinella, RA; Davis, TE
      Megestrol and tamoxifen in patients with advanced endometrial cancer - An Eastern Cooperative Oncology Group study (E4882)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    6. Bonner, JA; Sloan, JA; Rowland, KM; Klee, GG; Kugler, JW; Mailliard, JA; Wiesenfeld, M; Krook, JE; Maksymiuk, AW; Shaw, EG; Marks, RS; Perez, EA
      Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer

      CLINICAL CANCER RESEARCH
    7. Rajkumar, SV; Reid, JM; Novotny, PJ; Safgren, SL; Scheithauer, BW; Johnson, PS; Nair, S; Morton, RF; Hatfield, AK; Krook, JE; Ames, MM; Buckner, JC
      A randomized phase II and pharmacokinetic study of dacarbazine in patientswith recurrent glioma

      JOURNAL OF NEURO-ONCOLOGY
    8. Pitot, HC; Knost, JA; Mahoney, MR; Kugler, J; Krook, JE; Hatfield, AK; Sargent, DJ; Goldberg, RM
      A north central cancer treatment group phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

      CANCER
    9. Perez, EA; Hillman, DW; Stella, PJ; Krook, JE; Hartmann, LC; Fitch, TR; Hatfield, AK; Mailliard, JA; Nair, S; Kardinal, CG; Ingle, JN
      A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma

      CANCER
    10. Sargent, DJ; Goldberg, RM; Mahoney, MR; Hillman, DW; McKeough, T; Hamilton, SF; Darcy, JM; Anderson, VL; Krook, JE; O'Connell, MJ
      Rapid reporting and review of an increased incidence of a known adverse event

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    11. Ingle, JN; Suman, VJ; Johnson, PA; Krook, JE; Mailliard, JA; Wheeler, RH; Loprinzi, CL; Perez, EA; Jordan, VC; Dowsett, M
      Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer

      CLINICAL CANCER RESEARCH
    12. Bonner, JA; Sloan, JA; Shanahan, TG; Brooks, BJ; Marks, RS; Krook, JE; Gerstner, JB; Maksymiuk, A; Levitt, R; Mailliard, JA; Tazelaar, HD; Hillman, S; Jett, JR
      Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    13. Creagan, ET; Suman, VJ; Dalton, RJ; Pitot, HC; Long, HJ; Veeder, MH; Vukov, AM; Rowland, KM; Krook, JE; Michalak, JC
      Phase III clinical trial of the combination of cisplatin, dacarbazine, andcarmustine with or without tamoxifen in patients with advanced malignant melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    14. Loprinzi, CL; Kugler, JW; Sloan, JA; Mailliard, JA; Krook, JE; Wilwerding, MB; Rowland, KM; Camoriano, JK; Novotny, PJ; Christensen, BJ
      Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

      JOURNAL OF CLINICAL ONCOLOGY
    15. Burch, PA; Keppen, MD; Schroeder, G; Rubin, J; Krook, JE; Dalton, RJ; Gerstner, JB; Jancewicz, MT; Ebbert, LP
      North Central Cancer Treatment Group phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survivalas the primary endpoint of efficacy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    16. Tefferi, A; Levitt, R; Li, CY; Schroeder, G; Tschetter, LK; Michalak, JC; Krook, JE; Witzig, TE
      Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    17. Ingle, JN; Suman, VJ; Kardinal, CG; Krook, JE; Mailliard, JA; Veeder, MH; Loprinzi, CL; Dalton, RJ; Hartmann, LC; Conover, CA; Pollak, MN
      A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

      CANCER
    18. LLOYD RV; SCHROEDER G; BAUMAN MD; KROOK JE; JIN L; GOLDBERG RM; FARR GH
      PREVALENCE AND PROGNOSTIC-SIGNIFICANCE OF NEUROENDOCRINE DIFFERENTIATION IN COLORECTAL CARCINOMAS

      Endocrine pathology
    19. OCONNELL MJ; NAGORNEY DM; BERNATH AM; SCHROEDER G; FITZGIBBONS RJ; MAILLIARD JA; BURCH P; BOLTON JS; COLONOTERO G; KROOK JE
      SEQUENTIAL INTRAHEPATIC FLUORODEOXYURIDINE AND SYSTEMIC FLUOROURACIL PLUS LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL-CANCER CONFINED TO THE LIVER

      Journal of clinical oncology
    20. OCONNELL MJ; LAURIE JA; KAHN M; FITZGIBBONS RJ; ERLICHMAN C; SHEPHERD L; MOERTEL CG; KOCHA WI; PAZDUR R; WIEAND HS; RUBIN J; VUKOV AM; DONOHUE JH; KROOK JE; FIGUEREDO A
      PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER

      Journal of clinical oncology
    21. MILLER RC; MARTENSON JA; SARGENT DJ; KAHN MJ; KROOK JE
      ACUTE TREATMENT-RELATED DIARRHEA DURING POSTOPERATIVE ADJUVANT THERAPY FOR HIGH-RISK RECTAL-CARCINOMA

      International journal of radiation oncology, biology, physics
    22. CREAGAN ET; HESTORRF RD; SUMAN VJ; MAILLIARD JA; NAIR S; KROOK JE; KUGLER JW; MARSCHKE RF; MICHALAK JC; TSCHETTER LK
      COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY

      American journal of clinical oncology
    23. PATER JL; LOFTERS WS; ZEE B; DEMPSEY E; WALDE D; MOQUIN JP; WILSON K; HOSKINS P; GUEVIN RM; VERMA S; NAVARI R; KROOK JE; HAINSWORTH J; PALMER M; CHIN C
      THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY

      Annals of oncology
    24. LOFTERS WS; PATER JL; ZEE B; DEMPSEY E; WALDE D; MOQUIN JP; WILSON K; HOSKINS P; GUEVIN RM; VERMAN S; NAVARI R; KROOK JE; HAINSWORTH J; PALMER M; CHIN C
      PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY

      Journal of clinical oncology
    25. GOLDBERG RM; HATFIELD AK; KAHN M; SARGENT DJ; KNOST JA; OCONNELL MJ; KROOK JE; MAILLIARD JA; WIESENFELD M; SCHAEFER PL; TIRONA MT; MOERTEL CG
      PROSPECTIVELY RANDOMIZED NORTH CENTRAL CANCER-TREATMENT GROUP TRIAL OF INTENSIVE-COURSE FLUOROURACIL COMBINED WITH THE L-ISOMER OF INTRAVENOUS LEUCOVORIN, ORAL LEUCOVORIN, OR INTRAVENOUS LEUCOVORIN FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    26. INGLE JN; TWITO DI; SUMAN VJ; KROOK JE; MAILLIARD JA; WINDSCHITL HE; MARSCHKE RF
      EVALUATION OF INTRAVENOUS 6-THIOGUANINE AS FIRST-LINE CHEMOTHERAPY INWOMEN WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    27. ELLIOTT TE; DINAPOLI RP; OFALLON JR; KROOK JE; EARLE JD; MORTON RF; LEVITT R; TSCHETTER LK; SCHEITHAUER BW; PFEIFLE DM; TWITO DI; NELIMARK RA
      RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA

      Journal of neuro-oncology
    28. INGLE JN; KARDINAL CG; SUMAN VJ; KROOK JE; HATFIELD AK
      OCTREOTIDE AS FIRST-LINE TREATMENT FOR WOMEN WITH METASTATIC BREAST-CANCER

      Investigational new drugs
    29. ALBERTS SR; INGLE JN; ROCHE PR; CHA SS; WOLD LE; FARR GH; KROOK JE; WIEAND HS
      COMPARISON OF ESTROGEN-RECEPTOR DETERMINATIONS BY A BIOCHEMICAL LIGAND-BINDING ASSAY AND IMMUNOHISTOCHEMICAL STAINING WITH MONOCLONAL-ANTIBODY ER1D5 IN FEMALES WITH LYMPH-NODE POSITIVE BREAST-CARCINOMA ENTEREDON 2 PROSPECTIVE CLINICAL-TRIALS

      Cancer
    30. GOLDBERG RM; WIEAND HS; KROOK JE; SCHUTT AJ; VEEDER MH; MAILLAIRD JA; DALTON RJ
      A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA - REPLY

      Cancer
    31. GELBER RD; GOLDHIRSCH A; COLE BF; KROOK JE
      A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER - RESPONSE

      Journal of the National Cancer Institute
    32. GELBER RD; GOLDHIRSCH A; COLE BF; WIEAND HS; SCHROEDER G; KROOK JE
      A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER

      Journal of the National Cancer Institute
    33. WIESENFELD M; OCONNELL MJ; WIEAND HS; GONCHOROFF NJ; DONOHUE JH; FITZGIBBONS RJ; KROOK JE; MAILLIARD JA; GERSTNER JB; PAZDUR R
      CONTROLLED CLINICAL-TRIAL OF INTERFERON-GAMMA AS POSTOPERATIVE SURGICAL ADJUVANT THERAPY FOR COLON-CANCER

      Journal of clinical oncology
    34. GOLDBERG RM; LOPRINZI CL; MAILLIARD JA; OFALLON JR; KROOK JE; GHOSH C; HESTORFF RD; CHONG SF; REUTER NF; SHANAHAN TG
      PENTOXIFYLLINE FOR TREATMENT OF CANCER ANOREXIA AND CACHEXIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Journal of clinical oncology
    35. INGLE JN; KROOK JE; MAILLIARD JA; HARTMANN LC; WIEAND HS
      EVALUATION OF IFOSFAMIDE PLUS MESNA AS FIRST-LINE CHEMOTHERAPY IN WOMEN WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    36. LONG HJ; LANGDON RM; CHA SS; VEEDER MH; PFEIFLE DM; KROOK JE; EBBERT LP; TSCHETTER LK; ROSHON SG
      PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA

      Gynecologic oncology
    37. BUCKNER JC; BROWN LD; KUGLER JW; CASCINO TL; KROOK JE; MAILLIARD JA; KARDINAL CG; TSCHETTER LK; OFALLON JR; SCHEITHAUER BW
      PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA

      Journal of neurosurgery
    38. GOLDBERG RM; MOERTEL CG; WIEAND HS; KROOK JE; SCHUTT AJ; VEEDER MH; MAILLIARD JA; DALTON RJ
      A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA

      Cancer
    39. LOPRINZI CL; LAURIE JA; WIEAND HS; KROOK JE; NOVOTNY PJ; KUGLER JW; BARTEL J; LAW M; BATEMAN M; KLATT NE; DOSE AM; ETZELL PS; NELIMARK RA; MAILLIARD JA; MOERTEL CG
      PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES

      Journal of clinical oncology
    40. CULLINAN SA; MOERTEL CG; WIEAND HS; OCONNELL MJ; POON MA; KROOK JE; MAILLIARD JA; TSCHETTER LK
      CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER

      Journal of clinical oncology
    41. JETT JR; SU JQ; KROOK JE; GOLDBERG RM; KUGLER JW
      MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER

      Journal of clinical oncology
    42. JETT JR; MAKSYMIUK AW; SU JQ; MAILLIARD JA; KROOK JE; TSCHETTER LK; KARDINAL CG; TWITO DI; LEVITT R; GERSTNER JB
      PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    43. BUROKER TR; OCONNELL MJ; WIEAND HS; KROOK JE; GERSTNER JB; MAILLIARD JA; SCHAEFER PL; LEVITT R; KARDINAL CG; GESME DH
      RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    44. MAKSYMIUK AW; JETT JR; EARLE JD; SU JQ; DIEGERT FA; MAILLIARD JA; KARDINAL CG; KROOK JE; VEEDER MH; WIESENFELD M; TSCHETTER LK; LEVITT R
      SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL

      Journal of clinical oncology
    45. EARLE JD; FOLEY JF; WIEAND HS; KVOLS LK; MCKENNA PJ; KROOK JE; TSCHETTER LK; SCHUTT AJ; TWITO DI
      EVALUATION OF EXTERNAL-BEAM RADIATION-THERAPY PLUS 5-FLUOROURACIL (5-FU) VERSUS EXTERNAL-BEAM RADIATION-THERAPY PLUS HYCANTHONE (HYC) IN CONFINED, UNRESECTABLE PANCREATIC-CANCER

      International journal of radiation oncology, biology, physics
    46. OCONNELL M; MARTENSON JA; WIEAND HS; KROOK JE; MACDONALD JS; HALLER DG; MAYER RJ; GUNDERSON LL; RICH TA
      IMPROVING ADJUVANT THERAPY FOR RECTAL-CANCER BY COMBINING PROTRACTED-INFUSION FLUOROURACIL WITH RADIATION-THERAPY AFTER CURATIVE SURGERY

      The New England journal of medicine
    47. INGLE JN; KUROSS SA; MAILLIARD JA; LOPRINZI CL; JUNG SH; NELIMARK RA; KROOK JE; LONG HJ
      EVALUATION OF PIROXANTRONE IN WOMEN WITH METASTATIC BREAST-CANCER ANDFAILURE ON NONANTHRACYCLINE CHEMOTHERAPY

      Cancer
    48. HARTMANN LC; INGLE JN; WOLD LE; FARR GH; GRILL JP; SU JQ; MAIHLE NJ; KROOK JE; WITZIG TE; ROCHE PC
      PROGNOSTIC VALUE OF C-ERBB2 OVEREXPRESSION IN AXILLARY LYMPH-NODE POSITIVE BREAST-CANCER - RESULTS FROM A RANDOMIZED ADJUVANT TREATMENT PROTOCOL

      Cancer
    49. INGLE JN; FOLEY LF; MAILLIARD JA; KROOK JE; HARTMANN LC; JUNG SH; VEEDER MH; GESME DH; HATFIELD AK; GOLDBERG RM
      RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL WITH OR WITHOUT ESTROGENIC RECRUITMENT IN WOMEN WITH METASTATIC BREAST-CANCER

      Cancer
    50. CUNNINGHAM JM; INGLE JN; JUNG SH; CHA SS; WOLD LE; FARR G; WITZIG TE; KROOK JE; WIEAND HS; KOVACH JS
      P53 GENE-EXPRESSION IN NODE-POSITIVE BREAST-CANCER - RELATIONSHIP TO DNA-PLOIDY AND PROGNOSIS

      Journal of the National Cancer Institute
    51. DINAPOLI RP; BROWN LD; ARUSELL RM; EARLE JD; OFALLON JR; BUCKNER JC; SCHEITHAUER BW; KROOK JE; TSCHETTER LK; MAIER JA; PFEIFLE DM; GESME DH
      PHASE-III COMPARATIVE-EVALUATION OF PCNU AND CARMUSTINE COMBINED WITHRADIATION-THERAPY FOR HIGH-GRADE GLIOMA

      Journal of clinical oncology
    52. PISANSKY TM; INGLE JN; SCHAID DJ; HASS AC; KROOK JE; DONOHUE JH; WITZIG TE; WOLD LE
      PATTERNS OF TUMOR RELAPSE FOLLOWING MASTECTOMY AND ADJUVANT SYSTEMIC THERAPY IN PATIENTS WITH AXILLARY LYMPH NODE-POSITIVE BREAST-CANCER - IMPACT OF CLINICAL, HISTOPATHOLOGIC, AND FLOW CYTOMETRIC FACTORS

      Cancer
    53. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
      A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 17:09:30